Clinical Pearl: Ideal Candidates for Combination Therapy Patients that will greatly benefit from L-carnitine adjunctive therapy: Report persistent fatigue despite adequate weight loss on GLP-1 therapy alone Demonstrate signs of muscle loss or declining lean body mass during treatment Have plateaued in their weight loss despite medication optimization Present with metabolic syndrome features beyond elevated BMI (dyslipidemia, insulin resistance) Engage in regular physical activity and seek enhanced athletic performance alongside weight management Monitoring Parameters Regular assessment should include: Weight and body composition measurements every 4-6 weeks Lipid panel and HbA1c at 3-month intervals Liver function tests at baseline and 6 months (L-carnitine may affect hepatic fat metabolism) Patient-reported outcomes: energy levels, GI tolerability, exercise capacity Prescribing Patterns & Updates Growing Interest in Combination Metabolic Therapies Clinical practice patterns indicate increasing adoption of adjunctive therapies alongside GLP-1 medications
AHRQ Comparative Effectiveness Reviews
Symptoms may include hives, itching, swelling, dizziness, or difficulty breathing
Jan 5, 2023 Does Medicare cover Hyoscyamine
Generative AI statement The author(s) declare that no Gen AI was used in the creation of this manuscript
IV therapy can be beneficial for patients experiencing various health concerns, patients experiencing chronic pain or dehydration, as well as patients looking for a boost to their physical performance
